Skip to main content
SpringerLink
Log in

Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value

  • Original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

BACKGROUND: The diagnosis of inflammatory bowel disease (IBD), particularly the differentiation between ulcerative colitis (UC) and Crohn's disease (CD), is difficult and delayed in many cases, despite invasive diagnostic tools. AIMS: To determine the presence and evaluate the diagnostic accuracy of the potential serological diagnostic markers perinuclear antineutrophil cytoplasmic antibodies (pANCA), autoantibodies to intestinal goblet cells (GAB) and autoantibodies to exocrine pancreas (PAB), together with combinations of these, in the diagnosis of IBD and differential diagnosis of UC and CD. METHODS: The presence of pANCA, GAB and PAB was determined in indirect immunofluorescence assay of serum samples from 71 patients with IBD (CD 43, UC 28) and 41 healthy controls. The antigen specificity of ANCA was determined using ELISA. RESULTS: Compared with the control group, we confirmed a statistically significant presence of pANCA (71.4%) and GAB (46.4%) in patients with UC and the presence of PAB only in patients with CD (30.2%) (P < 0.001). In healthy controls, neither PAB nor GAB was detected and pANCA was present in only 4.8%. The sensitivity, specificity and positive and negative predictive values in differentiation of IBD from healthy controls were as follows: pANCA+: 71%, 95%, 91%, 83%; GAB+: 46%, 100%, 100%, 73%; PAB+: 30%, 100%, 100%, 58%; combination of (pANCA+ or GAB+)/PAB–: 82%, 95%, 92%, 87%; and to distinguish UC from CD: pANCA+: 71%, 98%, 95%, 84%; GAB+: 46%, 98%, 93%, 74%; PAB+: 30%, 100%, 100%, 48%; (pANCA+ or GAB+)/PAB–: 82%, 98%, 96%, 89%. CONCLUSIONS: All three autoantibodies may be helpful tools in non-invasive diagnosis and differential diagnosis of UC and CD. Combination of the autoantibodies may be particularly helpful, as the diagnostic sensitivity is considerably improved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Glickman RM (1980) Inflammatory bowel disease. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD (eds) Harrison's principles of internal medicine, 9th edn. McGraw-Hill, New York, pp 1403–11

    Google Scholar 

  • Kirschner BS (1995) Ulcerative colitis and Crohn's disease in children. Diagnosis and management. Ped Gastroenterol II 24: 99–117

    CAS  Google Scholar 

  • Sanders DSA (1996) The differential diagnosis of Crohn's disease and ulcerative colitis. Baillière's Clin Gastroenterol 12: 19–33

    Article  Google Scholar 

  • Krause S, Meier R, Wegmann W, Spichtin H, Aenishänslin HW (1998) Difficulties in differentiating Crohn's disease and ulcerative colitis. Praxis 87: 1607–11

    CAS  PubMed  Google Scholar 

  • Khulusi S, Rhodes J (1997) Diagnostic dilemmas in colitis. J Roy Coll Phys London 31: 618–23

    CAS  Google Scholar 

  • Cho JH, Brant SR (1998) Genetics and genetic markers in inflammatory bowel disease. Curr Opin Gastroenterol 14: 283–8

    Article  Google Scholar 

  • Koutrobakis I, Manousos ON, Mewwissen SGM, Pena AS (1996) Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43: 381–93

    Google Scholar 

  • Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol 115: 182–205

    Article  CAS  Google Scholar 

  • Schölmerich J (1996) Autoimmune Erkrankungen des Magen-Darm-Trakts. In: Peter HH, Pichler WJ (eds) Klinische Immunologie, 2. Aufl. Urban & Schwarzenberg, München Wien Baltimore, pp 532–46

    Google Scholar 

  • Ginsburg CH, Ault KA, Falchuk ZM (1981) Monoclonal B lymphocytes in the peripheral blood of patients with inflammatory bowel disease. Gastroenterology 81: 1111–4

    CAS  PubMed  Google Scholar 

  • Das KM (1999) Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Digestive Dis Sci 44: 1–13

    Article  CAS  Google Scholar 

  • Broberger O, Perlmann P (1959) Autoantibodies in human ulcerative colitis. J Exp Med 110: 657–74

    Article  CAS  PubMed  Google Scholar 

  • Shanahan F (1992) The role of autoantibodies and autoimmunity in chronic inflammatory disorders of the gut. Curr Opin Gastroenterol 8: 988–92

    Article  Google Scholar 

  • Stevens TR, Harley SL, Groom JS, Cambridge G, Leaker B, Blake DR, et al (1993) Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 38: 426–32

    Article  CAS  PubMed  Google Scholar 

  • Das KM, Dasgupta A, Mandal A, Geng X (1993) Autoimmunity to cytoskeletal protein tropomyosin: a clue to the pathogenetic mechanism for ulcerative colitis. Immunology 150: 2487–93

    CAS  Google Scholar 

  • Abad E, Tueal C, Mirapeix E, Cuxart A (1997) Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogenity. J Autoimmun 10: 175–80

    Article  CAS  PubMed  Google Scholar 

  • Terjung B, Herzog V, Worman HJ, Gestmann I, Bauer C, Sauerbruch T, et al (1998) Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins. Hepatology 28: 332–40

    Article  CAS  PubMed  Google Scholar 

  • Stöcker W, Otte M, Ulrich S, Normann D, Stöcker K, Jantschek G (1984) Autoantikörper gegen exokrines Pankreas und gegen intestinale Becherzellen in der Diagnostik des Morbus Crohn und der Colitis ulcerosa. Dtsch Med Wschr 109: 1963–1969

    PubMed  Google Scholar 

  • Hibi T, Ohara M, Kobayashi K, Brown WR, Toda K, Takaishi H, et al (1994) Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line patients with inflammatory bowel disease. Gut 35: 224–30

    Article  CAS  PubMed  Google Scholar 

  • Folwaczny C, Noehl N, Tschöp K, Endres SP, Heldwein W, Loeschke K, et al (1997) Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives. Gastroenterol 133: 101–6

    Article  Google Scholar 

  • Takaishi H, Ohara S, Hotta K, Yajima T, Kanai T, Inoue N, et al (2000) Circulating autoantibodies against purified colonic mucin in ulcerative colitis. J Gastroenterol 35: 20–7

    Article  CAS  PubMed  Google Scholar 

  • Stöcker W, Otte M, Ulrich S, Normann D, Finkbeiner H, Stöcker K, et al (1987) Autoimmunity to pancreatic juice in Crohn's disease. J Gastroenterol 22[Suppl 139]: 41–52

    Google Scholar 

  • Sasse EA (1996) Reference intervals and clinical decision limits. In: Kaplan LA, Pesce AJ (eds) Clinical chemistry: theory, analysis, correlation, 3rd edn. Mosby-Year Book Inc., St Louis, pp 365–81

    Google Scholar 

  • Falk RJ, Jenette JC (1988) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and crescentic glomerulonephritis. N Engl J Med 318: 1651–7

    CAS  PubMed  Google Scholar 

  • Peeters M, Joossens S, Vermeire SV, Vlietinck R, Bossuyt X, Rutgeerts P (2001) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 96: 730–4

    Article  CAS  PubMed  Google Scholar 

  • Roozendaal C, Pogany K, Horst G, Jagt TG, Kleibeuker JH, Nelis GF, et al (1999) Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases? Scand J Gastroenterol 34: 1123–31

    Article  CAS  PubMed  Google Scholar 

  • Radice A, Vecchi M, Bianchi MB, Sinico RA (2000) Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheumatol 18: 707–12

    CAS  PubMed  Google Scholar 

  • Eggena M, Cohavy O, Parseghian MH, Hamkalo BA, Clemens D, Targan SR, et al (2000) Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 14: 83–97

    Article  CAS  PubMed  Google Scholar 

  • Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, et al (1997) Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 107: 135–40

    Article  CAS  PubMed  Google Scholar 

  • Mallolas J, Esteve M, Rius E, Cabré E, Gassull MA (2000) Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis. Gut 47: 74–8

    Article  CAS  PubMed  Google Scholar 

  • Wiik A (2002) Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases. Autoimmun Rev 1: 67–72

    Article  CAS  PubMed  Google Scholar 

  • Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, et al (1996) Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin Exp Immunol 105: 120–4

    Article  CAS  PubMed  Google Scholar 

  • Yang P, Bohr J, Tysk C, Danielsson D, Järnerot G (1996) Antineutrophil cytoplasmic antibodies in inflammatory bowel disease and collagenous colitis: no association with lactoferrin, β-glucorinidase, myeloperoxidase, or proteinase 3. Inflamm Dis 2: 173–7

    Article  Google Scholar 

  • Kuwana T, Sato Y, Saka M, Kondo Y, Miyata M, Obara K, et al (2000) Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J Gastroenterol 35: 682–9

    Article  CAS  PubMed  Google Scholar 

  • Seibold F, Weber P, Jenss H, Wiedmann KH (1991) Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patient with Crohn's disease. Gut 32: 1192–7

    Article  CAS  PubMed  Google Scholar 

  • Goischke EM, Zilly W (1992) Klinische Bedeutung organspezifische Antikörper bei Colitis ulcerosa und Morbus Crohn. Z Gastroenterol 30: 319–24

    CAS  PubMed  Google Scholar 

  • Seibold F, Mörk H, Tanza S, Müller, Holzhüter C, Weber P, et al (1997) Pancreatic autoantibodies in Crohn's disease: a family study. Gut 40: 481–4

    CAS  PubMed  Google Scholar 

  • Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al (1998) Anti-Saccharomices cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42: 788–91

    CAS  PubMed  Google Scholar 

  • Ruemmele FM, Targan SR, Levy G, et al (1998) Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterol 115: 822–9

    Article  CAS  Google Scholar 

  • Dietrich W, Ehnis T, Bauer M, Donner P, Volta U, Ricken EO, et al (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3: 797–801

    Article  Google Scholar 

  • Unger F (2008) Health is wealth – Toward a European lead market in health care. Acta Medico-Biotechnica 1: 11–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Diagnosis, University Medical Center Maribor, Maribor, Slovenia

    Evgenija Homšak

  2. Department of Pediatrics, University Medical Center Maribor, Maribor, Slovenia

    Dušanka Mičetić-Turk

  3. Department of Rheumatology, University Medical Center, Ljubljana, Slovenia

    Borut Božič

  4. Faculty of Medicine, University of Maribor, Maribor, Slovenia

    Evgenija Homšak & Dušanka Mičetić-Turk

Authors
  1. Evgenija Homšak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dušanka Mičetić-Turk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Borut Božič
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evgenija Homšak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Homšak, E., Mičetić-Turk, D. & Božič, B. Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Wien Klin Wochenschr 122 (Suppl 2), 19–25 (2010). https://doi.org/10.1007/s00508-010-1344-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-010-1344-y

Keywords

Search

Navigation